• Strata Critical Medical director Andrew Lauck purchased 2,000 shares of Class A common stock at $4.999 each.
• The purchase increased his direct holdings to 172,902 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Strata Critical Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-071913), on November 09, 2026, and is solely responsible for the information contained therein.